Sotera Health Co
NASDAQ:SHC
Intrinsic Value
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. [ Read More ]
The intrinsic value of one SHC stock under the Base Case scenario is 21.83 USD. Compared to the current market price of 10.9 USD, Sotera Health Co is Undervalued by 50%.
Valuation Backtest
Sotera Health Co
Run backtest to discover the historical profit from buying and selling SHC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sotera Health Co
Current Assets | 557.2m |
Cash & Short-Term Investments | 296.4m |
Receivables | 176.2m |
Other Current Assets | 84.6m |
Non-Current Assets | 2.6B |
PP&E | 971m |
Intangibles | 1.5B |
Other Non-Current Assets | 81.6m |
Current Liabilities | 230.7m |
Accounts Payable | 71m |
Accrued Liabilities | 124.5m |
Other Current Liabilities | 35.1m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 2.3B |
Other Non-Current Liabilities | 168.6m |
Earnings Waterfall
Sotera Health Co
Revenue
|
1B
USD
|
Cost of Revenue
|
-472.1m
USD
|
Gross Profit
|
577.2m
USD
|
Operating Expenses
|
-300.5m
USD
|
Operating Income
|
276.7m
USD
|
Other Expenses
|
-225.6m
USD
|
Net Income
|
51.1m
USD
|
Free Cash Flow Analysis
Sotera Health Co
What is Free Cash Flow?
SHC Profitability Score
Profitability Due Diligence
Sotera Health Co's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Sotera Health Co's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
SHC Solvency Score
Solvency Due Diligence
Sotera Health Co's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Sotera Health Co's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SHC Price Targets Summary
Sotera Health Co
According to Wall Street analysts, the average 1-year price target for SHC is 17.24 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.
Ownership
SHC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SHC Price
Sotera Health Co
Average Annual Return | -23.48% |
Standard Deviation of Annual Returns | 36.87% |
Max Drawdown | -79% |
Market Capitalization | 3.1B USD |
Shares Outstanding | 282 620 000 |
Percentage of Shares Shorted | 10.89% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The firm operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterilization Services includes products, such as procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers, including personal protective equipment (PPE), laboratory products and pharmaceuticals. Its lab testing and advisory services offer microbiological and analytical chemistry laboratory tests across the medical device and pharmaceutical industries. Its medical device testing services include microbiology, biocompatibility and toxicology assessments, material characterization, sterilization validation, sterility assurance. Its pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and leachables evaluations of pharmaceutical containers.
Contact
IPO
Employees
Officers
The intrinsic value of one SHC stock under the Base Case scenario is 21.83 USD.
Compared to the current market price of 10.9 USD, Sotera Health Co is Undervalued by 50%.